共 50 条
- [1] Long-term safety and efficacy of daclizumab beta in relapsing-remitting multiple sclerosis: 6-year results from the SELECTED open-label extension studyJOURNAL OF NEUROLOGY, 2020, 267 (10) : 2851 - 2864Gold, RalfRadue, Ernst-WilhelmGiovannoni, GavinSelmaj, KrzysztofHavrdova, Eva KubalaMontalban, XavierStefoski, DusanSprenger, TillRobinson, Randy R.Fam, SamiSmith, JonathanChalkias, SpyrosGiannattasio, GiorgioLima, GabrielCastro-Borrero, Wanda
- [2] Improved cognitive outcomes in patients with relapsing-remitting multiple sclerosis treated with daclizumab beta: Results from the DECIDE studyMULTIPLE SCLEROSIS JOURNAL, 2018, 24 (06) : 795 - 804Benedict, Ralph H. B.Cohan, StanleyLynch, Sharon G.Riester, KatherineWang, PingCastro-Borrero, WandaElkins, JacobSabatella, Guido
- [3] Long-term treatment with darifenacin for overactive bladder: results of a 2-year, open-label extension studyBJU INTERNATIONAL, 2006, 98 (05) : 1025 - 1032Haab, FrancoisCorcos, JacquesSiami, PaulGlavind, KarinDwyer, PeterSteel, MichaelKawakami, FernandoLheritier, KarineSteers, William D.
- [4] Long-term safety and efficacy of lanreotide autogel in Japanese patients with neuroendocrine tumors: Final results of a phase II open-label extension studyASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 (05) : E153 - E161Ito, TetsuhideFujimori, NaoHonma, YoshitakaKudo, AtsushiHijioka, SusumuKatsushima, ShinjiKimura, YasutoshiFukutomi, AkiraHisamatsu, SeiichiNakajima, AkihiroShimatsu, Akira
- [5] Long-term safety and efficacy of dalfampridine for walking impairment in patients with multiple sclerosis: Results of open-label extensions of two Phase 3 clinical trialsMULTIPLE SCLEROSIS JOURNAL, 2015, 21 (10) : 1322 - 1331Goodman, Andrew D.Bethoux, FrancoisBrown, Theodore R.Schapiro, Randall T.Cohen, RonMarinucci, Lawrence N.Henney, Herbert R.Blight, Andrew R.
- [6] Long-Term Efficacy and Safety of Ozanimod in Moderately to Severely Active Ulcerative Colitis: Results From the Open-Label Extension of the Randomized, Phase 2TOUCHSTONE StudyJOURNAL OF CROHNS & COLITIS, 2021, 15 (07) : 1120 - 1129Sandborn, William J.Feagan, Brian G.Hanauer, StephenVermeire, SeverineGhosh, SubrataLiu, Wenzhong J.Petersen, AnnKatrinCharles, LornaHuang, VivianUsiskin, KeithWolf, Douglas C.D'Haens, Geert
- [7] Long-term efficacy and safety of migalastat treatment in Fabry disease: 30-month results from the open-label extension of the randomized, phase 3 ATTRACT studyMOLECULAR GENETICS AND METABOLISM, 2020, 131 (1-2) : 219 - 228Feldt-Rasmussen, UllaHughes, DerralynnSunder-Plassmann, GereShankar, SumaNedd, KhanOlivotto, IacopoOrtiz, DamaraOhashi, ToyaHamazaki, TakashiSkuban, NinaYu, JulieBarth, Jay A.Nicholls, Kathleen
- [8] Long-term efficacy and safety of inotersen for hereditary transthyretin amyloidosis: NEURO-TTR open-label extension 3-year updateJOURNAL OF NEUROLOGY, 2022, 269 (12) : 6416 - 6427Brannagan, Thomas H.Coelho, TeresaWang, Annabel K.Polydefkis, Michael J.Dyck, Peter J.Berk, John L.Drachman, BrianGorevic, PeterWhelan, CarolConceicao, IsabelPlante-Bordeneuve, ViolaineMerlini, GiampaoloObici, LauraCampistol Plana, Josep MariaGamez, JosepKristen, Arnt, VMazzeo, AnnaGentile, LucaNarayana, ArvindOlugemo, KemiAquino, PeterBenson, Merrill D.Gertz, Morie
- [9] Long-term efficacy and safety of inotersen for hereditary transthyretin amyloidosis: NEURO-TTR open-label extension 3-year updateJournal of Neurology, 2022, 269 : 6416 - 6427Thomas H. BrannaganTeresa CoelhoAnnabel K. WangMichael J. PolydefkisPeter J. DyckJohn L. BerkBrian DrachmanPeter GorevicCarol WhelanIsabel ConceiçãoViolaine Plante-BordeneuveGiampaolo MerliniLaura ObiciJosep Maria Campistol PlanaJosep GamezArnt V. KristenAnna MazzeoLuca GentileArvind NarayanaKemi OlugemoPeter AquinoMerrill D. BensonMorie Gertz
- [10] Long-term efficacy and safety of adalimumab in patients with moderate to severe psoriasis treated continuously over 3 years: Results from an open-label extension study for patients from REVEALJOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2012, 66 (02) : 241 - 251Gordon, KennethPapp, KimPoulin, YvesGu, YihuaRozzo, StephenSasso, Eric H.